Teladoc Health, Inc. Gross Profit

• Teladoc Health, Inc. showed an increase of +68.5% in Gross Profit from 2017 to 2018.
• This data is from Teladoc Health, Inc.'s annual report (Form 10-K), filed with the SEC on February 27, 2019.
• XBRL data for this metric is available from 2013 to 2018 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2014: $8.26 million | Q3 2014: $8.75 million | Q1 2015: $11.21 million | Q2 2015: $13.49 million | Q3 2015: $15.49 million | Q1 2016: $18.95 million | Q2 2016: $19.60 million | Q3 2016: $25.27 million | Q4 2016: $27.38 million | Q1 2017: $30.76 million | Q2 2017: $34.57 million | Q3 2017: $51.91 million | Q4 2017: $54.42 million | Q1 2018: $62.79 million | Q2 2018: $66.88 million | Q3 2018: $76.80 million | Q4 2018: $82.71 million | Q1 2019: $83.90 million.
• Over the full 6 years of available data (2013 to 2018), Teladoc Health, Inc.'s Gross Profit has grown by 1,739.5%.
• Historical annual values: Fiscal year 2018: $289.17 million | Fiscal year 2017: $171.66 million | Fiscal year 2016: $91.19 million | Fiscal year 2015: $56.34 million | Fiscal year 2014: $33.60 million | Fiscal year 2013: $15.72 million.
• Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: August 9, 2026